menu
The antibody discovery services market is estimated to be worth around USD 6.5
The antibody discovery services market is estimated to be worth around USD 6.5
The antibody discovery services market is estimated to be worth around USD 6.5 billion

The antibody discovery services market is estimated to be worth around USD 6.5 billion

Antibody therapeutics have made it possibleto address the hard to target hotspots, rendering the domain of antibodydiscovery an emerging sector in the pharmaceutical industry; in fact, theantibodies have proven to be promising weapons in the battle against COVID-19pandemic.

 

Roots Analysis is pleased to announce the publication of its recent study,titled, “Antibody Discovery: Services and Platforms Market (3rdEdition), 2020-2030.”

 

Thereport features an extensive study of the current market landscape, offering aninformed opinion on the likely evolution in this industry over the next tenyears. It features an in-depth analysis of the antibody discovery technologiesand services that assist in the development of antibody therapeutics. Inaddition to other elements, the study includes:

§ A detailed overviewof the overall landscape of antibody discovery service providers along with theinformation on a number of relevant parameters.

§ An insightfulcompetitiveness analysis of antibody discovery service providers based onvarious relevant parameters, such as supplier power and service portfolio specifications.

§ Elaborate profiles ofthe prominent companies that provide antibody discovery services.

§ A detailed review of theoverall landscape of antibody discovery platforms, along with the informationon the technology developers.

§ An in-depth analysisof antibody discovery platforms, taking into consideration the supplier powerand key technology specifications.

§ Elaborate profiles ofthe companies providing antibody discovery technologies / platforms.

§ An assessment ofantibody discovery service and platform providers’ capability in differentregions.

§ An analysis of thepartnerships that have been established in the period between 2015 and 2020.

§ An analysis of theinvestments made in this domain, during the period between 2016 and 2020 (tillApril), in companies that are engaged in the field of antibody drug discovery.

§ Detailed profiles onthe top five therapeutic antibody products, which have generated the highestrevenues.

§ A case study onantibody humanization and affinity maturation, highlighting key players, theongoing research trends and the major challenges in this field.

§ A detailed marketforecast, featuring analysis of the financial opportunity within the antibodydiscovery services market across the following segments:

§ Steps Involved in theAntibody Discovery Process

§ Antigen Designing

§ Hit Generation

§ Lead Selection

§ Lead Optimization

§ Lead Characterization

 

§ Antibody DiscoveryMethod Used

§ Phage Display

§ Hybridoma

§ Transgenic Animal

§ Yeast Display

§ Single Cell

§ Others

 

§ Nature of AntibodyGenerated

§ Humanized

§ Human

§ Chimeric

§ Murine

 

PressRelease: Variation 1 (Format 2)

 

§ Key GeographicalRegions 

§ North America

§ Europe

§ Asia Pacific and Restof the World

§ A detailed marketforecast, featuring analysis of the financial opportunity within the antibodydiscovery services market across the following segments:

§ Type of Payment

§ Upfront Payments

§ Milestone Payments

 

§ Key GeographicalRegions 

§ North America

§ Europe

§ Asia Pacific

 

Key companies covered in the report:

§ Abzena

§ Abwiz Bio

§ Aragen Bioscience

§ BIOTEM

§ ChemPartner

§ Creative Biolabs

§ Distributed Bio

§ Harbour BioMed

§ HD Biosciences

§ ImmunoPrecise Antibodies

§ Integral Molecular

§ Kymab

§ LakePharma

§ Ligand Pharmaceuticals

§ MorphoSys

§ PX’Therapeutics

§ Syd Labs

§ Viva Biotech

§ Wuxi Biologics

 

Formore information, please click on the following link: 

https://www.rootsanalysis.com/reports/view_document/antibody-discovery-services-and-platforms/213.html

 

Other recent offerings:

1.    Antibody ContractManufacturing Market, 2020 – 2030

2.    AntibodyDrug Conjugates Market (5th Edition), 2019-2030

3.    Antibody DrugConjugates (ADCs) – Linker and Conjugation Technologies Market, 2019-2030

 

About Roots Analysis

Roots Analysis is oneof the fastest growing market research companies, sharing fresh and independentperspectives in the bio-pharmaceutical industry. The in-depth research,analysis and insights are driven by an experienced leadership team which hasgained many years of significant experience in this sector. If you’d like helpwith your growing business needs, get in touch at info@rootsanalysis.com

 

Contact Information

Roots AnalysisPrivate Limited

Gaurav Chaudhary

+1 (415) 800 3415

Gaurav.Chaudhary@rootsanalysis.com